454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples. OncoTargets and Therapy
Subscribe to Our Newsletter
You are leaving the U.S. & Canada Research Use Only (RUO) area.
The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.